ORTH ANDREW C. 4
4 · Krystal Biotech, Inc. · Filed Jun 2, 2021
Insider Transaction Report
Form 4
ORTH ANDREW C.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-31+205,000→ 205,000 totalExercise: $65.24Exp: 2031-05-31→ Common Stock (205,000 underlying)
Holdings
- 100
Common Stock
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on May 3, 2022.